NUS Nu Skin Enterprises, Inc. Common Stock
NYSE · Consumer products · Wyświetl na SEC EDGAR ↗ zamknij Paź 2, 2026 10-K/10-Q Sie 10, 2026NUS Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
NUS Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O Nu Skin Enterprises, Inc. Common Stock Przegląd firmy z Wikipedii
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors. The company was founded in 1984 by Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund.
History
In 1984, Nu Skin founders Blake Roney, Nedra Roney, Sandie Tillotson, and Steven J. Lund launched a line of skincare products using only natural ingredients. The founders aimed to create skincare products and nutritional products without unnecessary fillers with the philosophy of “all of the good, none of the bad.”
The company first served the United States market and expanded operations to Canada in 1990. In 1991, the company began operations in Asia, starting in Hong Kong. In 1996, the company listed on the New York Stock Exchange.
In 1992, Nu Skin settled with five states that accused the company of deceptive advertising and overstating distributor income. In 1994, the company paid $1 million and signed a consent decree with the FTC prohibiting it from making deceptive product claims. In 1997, the company paid an additional $1.5 million to the FTC to settle allegations of unsubstantiated claims.
In 1998, Nu Skin acquired Generation Health, the parent company of the dietary supplement company Pharmanex. According to Women's Health Letter, the Pharmanex device was designed merely to help sell more supplements, since per Nu Skin's 2002 annual report, "as customers track their skin carotenoid content, we believe they will be motivated to consistently consume LifePak for longer periods of time."
In the late 1990s, Nu Skin invested in Big Planet, a multilevel marketing company selling Internet services. The New York Times wrote that Big Planet recruited people "even if they have little knowledge of the technology that they are supposed to be selling," with a Big Planet representative quoted: "I believe people who have never touched a computer before can become hugely wealthy in this business."
In 2009, Nu Skin began working with LifeGen Technologies, a genomics company based in Madison, Wisconsin. Nu Skin acquired LifeGen in December 2011. Nu Skin claims LifeGen's genetic database aided in the development of Nu Skin's products, launching the ageLOC brand.
In 2016, Nu Skin paid a $47 million class-action settlement, citing failure to disclose that its Chinese subsidiary did not register as the direct seller. Nu Skin paid $750k in fines to the United States Securities and Exchange Commission following allegations of a bribe that saw charity funds go to a Chinese politician.
In 2021, Nu Skin's subsidiary Rhyz Inc. acquired social commerce company Mavely and acquired Dallas-based skincare company BeautyBio in 2023. In 2025, the company sold the Mavely platform for five times what it paid for the company in 2021, in a $250 million transaction to Later, the Summit Partners company.
Products
Nu Skin was granted a patent on a device developed by Pharmanex called a "BioPhotonic Scanner", which is designed to measure the carotenoid level in skin. The company launched its ageLOC anti-aging brand in 2008.
In 2014, Nu Skin launched the Nu Skin Facial Spa which received FDA clearance for over-the-counter cosmetic use. In 2018, the company introduced the ageLOC LumiSpa, a dual-action skin care device that uses a soft silicone treatment head to gently cleanse away dirt, oil, and makeup.
Nu Skin launched ageLOC LumiSpa iO, the company's first connected device, in 2022. LumiSpa iO is a smart treatment and cleansing device for customized skin care, popularized by Venus Williams. Nu Skin launched Nu Colour “Lash + Brow” in 2023, marketed as free of prostaglandins. In 2022, Nu Skin launched a line of Nutricentials Bioadaptive Skin Care Pumps. In 2024, the company launched Nu Skin RenuSpa iO, an FDA-cleared microcurrent body device with a connected app to view live insights during treatment. RenuSpa iO is the company's first integrated beauty and wellness device. In 2024, Nu Skin launched MYND360 as a supplement and topicals product line for cognitive health.
Reception
Nu Skin Enterprises' is a multi-level marketing business. Each distributor markets products directly to potential customers and may also recruit and train customers to become distributors. Distributors are paid on the retail markup on products they are able to sell, as well as a performance bonus based on the sales of recruited distributors. In the early 1990s, Nu Skin was investigated by Connecticut, Pennsylvania, Florida, Illinois, Ohio, and Michigan over allegations of misleading marketing practices. In 1992 the company settled with five of the states, admitted no wrongdoing but agreed to pay the states' investigative costs, refund distributors, and revamp its promotional practices. The Connecticut Attorney General did not agree to those terms and sued Nu Skin, alleging the company misled its distributors and operated a pyramid scheme. Nu Skin admitted to no wrongdoing or violation of law and settled with the state for $85k for consumer-protection programs.
In 1997, the Attorney General of Pennsylvania alleged in a lawsuit that Nu Skin operated a pyramid scheme through a subsidiary, QIQ Connections and that distributors paid for the right to market technology services that did not, in fact, exist. Nu Skin discontinued the QIQ subsidiary, allowing those who had paid QIQ to move to Big Planet, a Nu Skin investment marketing Internet technology. The president of Big Planet described the allegations as a matter of "a few distributors who in their enthusiasm have been overzealous in some of their marketing activities."
In 2010, Nu Skin was listed among Forbes "100 Most Trustworthy Companies".
In 2011, two Utah-incorporated business entities linked to top executives of Nu Skin each made a $1 million contribution to Restore Our Future, a Super PAC established by former aides to U.S. presidential candidate Mitt Romney to support his bid for the White House.
In 2012, Stanford University apologized for an misunderstanding following a cease and desist letter sent to halt the use of the name of one of its researchers, Dr. Stuart Kim, in Nu Skin's advertising. Also in 2012, Citron Research issued a report "stating that Nu Skin's sales model on mainland China, the fastest growing market in direct-selling, amounted to an illegal multilevel marketing scheme." Nu Skin dismissed the claims, calling its sales model in China "kosher" and stating that it had no plans to change its business model. In 2014, The Chinese government investigated Nu Skin following a People's Daily newspaper report calling it a "suspected illegal pyramid scheme." Following the investigation, the Chinese government fined Nu Skin for $540k due to illegal sales and making false product claims.
In February 2014, a press release shows a class action lawsuit filed in the U.S. District Court for the District of Utah against Nu Skin Enterprises on behalf of investors who acquired stock of the company from July 2013, to January 2014.
In a Last Week Tonight with John Oliver segment that covered multilevel marketing companies, Oliver criticized Nu Skin for the fact that in 2015, 93% of its distributors did not earn a commission check in a typical month. Nu Skin says it pays approximately 43 percent of its product revenue in sales compensation.
In 2025, Nu Skin was named to USA Today's list of "best customer service."
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | NUS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -1.0średnia z 5 lat ≈30.6 | ≈30.6 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | NUS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 69.2%średnia z 5 lat ≈70.6% | ≈70.6% | 68.4% | Słaby | |
| Marża Operacyjna (TTM) | -0.76%średnia z 5 lat ≈2.4% | ≈2.4% | 2.4% | Słaby | |
| Marża EBITDA (TTM) | 2.9%średnia z 5 lat ≈5.8% | ≈5.8% | 2.4% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -1.9%średnia z 5 lat ≈3.4% | ≈3.4% | -2.0% | Słaby | |
| Marża Zysku Netto (TTM) | -15.7%średnia z 5 lat ≈2.6% | ≈2.6% | -3.7% | Słaby | |
| ROA (TTM) | -16.9%średnia z 5 lat ≈3.2% | ≈3.2% | 5.6% | Najwyższa półka | |
| ROE (TTM) | -32.5%średnia z 5 lat ≈6.2% | ≈6.2% | 13.7% | Najwyższa półka | |
| ROIC | 5.2%średnia z 5 lat ≈3.2% | ≈3.2% | 5.2% | Zgodnie z |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | NUS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.4średnia z 5 lat ≈0.5 | ≈0.5 | 0.1 | Wysokie zadłużenie | |
| Wskaźnik bieżący (MRQ) | 2.0średnia z 5 lat ≈2.0 | ≈2.0 | 2.0 | Zgodnie z | |
| Wskaźnik Szybkości (MRQ) | 0.9średnia z 5 lat ≈0.9 | ≈0.9 | 0.6 | Silna płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.4średnia z 5 lat ≈0.4 | ≈0.4 | · | · |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | NUS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -14.3%średnia z 5 lat ≈-10.2% | ≈-10.2% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -12.6%średnia z 5 lat ≈-11.7% | ≈-11.7% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -10.5% | · | · | · | |
| EPS YoY | -91.8%średnia z 5 lat ≈-46.9% | ≈-46.9% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -91.8%średnia z 5 lat ≈-47.9% | ≈-47.9% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 15.4% | · | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | -2.6% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 15.2% | · | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -3.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | NUS | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.0średnia z 5 lat ≈1.2 | ≈1.2 | 1.0 | Zgodnie z | |
| Inventory Turnover (Rotacja zapasów) | 2.5średnia z 5 lat ≈2.1 | ≈2.1 | 3.1 | Słaby | |
| Receivables Turnover (Rotacja należności) | 32.9średnia z 5 lat ≈39.8 | ≈39.8 | 15.7 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$530.4K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Sie 28, 2026 | $0,06 | USD | ≈4.9% |
| Maj 29, 2026 | $0,06 | USD | ≈4.1% |
| Lut 27, 2026 | $0,06 | USD | ≈2.8% |
| Lis 28, 2025 | $0,06 | USD | ≈2.4% |
| Sie 29, 2025 | $0,06 | USD | ≈2.0% |
| Maj 30, 2025 | $0,06 | USD | ≈2.8% |
| Lut 24, 2025 | $0,06 | USD | ≈3.1% |
| Lis 29, 2024 | $0,06 | USD | ≈3.3% |
| Sie 30, 2024 | $0,06 | USD | ≈6.4% |
| Maj 31, 2024 | $0,06 | USD | ≈6.7% |
| Lut 23, 2024 | $0,06 | USD | ≈9.8% |
| Lis 22, 2023 | $0,39 | USD | ≈9.2% |
| Sie 24, 2023 | $0,39 | USD | ≈6.7% |
| Maj 25, 2023 | $0,39 | USD | ≈4.5% |
| Lut 24, 2023 | $0,39 | USD | ≈3.8% |
| Lis 23, 2022 | $0,39 | USD | ≈4.0% |
| Sie 25, 2022 | $0,39 | USD | ≈3.5% |
| Maj 26, 2022 | $0,39 | USD | ≈3.4% |
| Lut 25, 2022 | $0,39 | USD | ≈3.2% |
| Lis 24, 2021 | $0,38 | USD | ≈3.3% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 5, 2026 | $0.20 | $0.20 | -0.99% |
| 31 marca 2026 | $0.14 | $0.15 | -7.6% | |
| 31 grudnia 2025 | $0.29 | $0.30 | -4.3% | |
| 30 września 2025 | $0.34 | $0.30 | 12.2% | |
| 30 czerwca 2025 | $0.43 | $0.25 | 73.7% | |
| 31 marca 2025 | $0.23 | $0.13 | 73.8% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | $2.21B | $2.25B | |
| Cost of Revenue | $454M | $550M | $612M | $631M | $675M | $658M | $581M | $634M | $502M | $500M | $490M | |
| Gross Profit | $1.03B | $1.18B | $1.36B | $1.59B | $2.02B | $1.92B | $1.84B | $2.04B | $1.78B | $1.71B | $1.76B | |
| R&D Expense | $11M | $13M | $23M | $23M | $27M | $23M | $30M | $23M | $22M | $24M | $20M | |
| SG&A Expense | $432M | $479M | $547M | $556M | $654M | $636M | $616M | $662M | $565M | $554M | $561M | |
| Operating Expenses | $966M | $1.33B | $1.31B | $1.48B | $1.79B | $1.67B | $1.57B | $1.80B | $1.50B | $1.48B | $1.51B | |
| Operating Income | $66M | $-152M | $48M | $111M | $234M | $258M | $267M | $241M | $274M | $231M | $245M | |
| Interest Expense | · | · | $26M | $14M | $11M | $13M | $19M | $22M | $22M | $16M | $8M | |
| Other Non-op | $-32M | $3M | $4M | $-8M | $-2M | $-1M | $-12M | $-21M | $-9M | $-18M | $-33M | |
| Pretax Income | $196M | $-175M | $27M | $89M | $232M | $256M | $255M | $220M | $266M | $213M | $212M | |
| Income Tax | $36M | $-28M | $18M | $-16M | $85M | $65M | $82M | $98M | $136M | $70M | $79M | |
| Net Income | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | $143M | $133M | |
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 | $2.29 | |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 | $2.25 | |
| Shares (Basic) | 49,293,000 | 49,662,000 | 49,711,000 | 50,002,000 | 50,193,000 | 52,296,000 | 55,518,000 | 55,170,000 | 52,806,000 | 55,412,000 | 57,997,000 | |
| Shares (Diluted) | 50,301,000 | 49,662,000 | 49,860,000 | 50,525,000 | 51,427,000 | 52,765,000 | 55,927,000 | 56,476,000 | 54,852,000 | 56,097,000 | 59,057,000 | |
| EBITDA | $118M | $-82M | $119M | $183M | $310M | $332M | $344M | $324M | $346M | · | $316M |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $239M | $187M | $256M | $265M | $340M | $403M | $336M | $387M | $426M | $357M | $289M | |
| Short-term Investments | $1M | $11M | $12M | $14M | $15M | $21M | $8M | $11M | $12M | $11M | $14M | |
| Receivables | $40M | $51M | $59M | $47M | $41M | $63M | $50M | · | · | · | · | |
| Inventory | $179M | $190M | $280M | $346M | $400M | $314M | $276M | $296M | $253M | $250M | $265M | |
| Prepaid Expense | $90M | $73M | $81M | $88M | $77M | $102M | $70M | $52M | $53M | $65M | $102M | |
| Other Current Assets | $13M | $14M | $18M | $18M | $18M | $15M | $16M | $16M | $14M | $13M | $14M | |
| Current Assets | $548M | $539M | $702M | $760M | $873M | $903M | $740M | $799M | $778M | $714M | $706M | |
| PP&E (Net) | $377M | $380M | $433M | $445M | $454M | $468M | $454M | $465M | $465M | $445M | $455M | |
| PP&E (Gross) | $768M | $733M | $788M | $787M | $819M | $818M | $785M | $788M | $751M | $678M | $666M | |
| Accum. Depreciation | $391M | $353M | $355M | $342M | $366M | $350M | $331M | $323M | $286M | $234M | $212M | |
| Goodwill | $84M | $84M | $218M | $206M | $206M | $203M | $197M | $197M | $115M | $115M | $112M | |
| Intangibles | $43M | $74M | $95M | $67M | $77M | $90M | $80M | $90M | $68M | $64M | $67M | |
| Other Non-current Assets | $280M | $298M | $248M | $244M | $175M | $138M | $154M | $144M | $165M | $136M | $165M | |
| Total Assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B | |
| Accounts Payable | $26M | $35M | $43M | $54M | $50M | $66M | $39M | $48M | $50M | $41M | $29M | |
| Accrued Liabilities | $218M | $218M | $254M | $280M | $372M | $447M | $290M | $323M | $319M | $275M | $311M | |
| Current Liabilities | $264M | $297M | $329M | $359M | $530M | $543M | $357M | $440M | $447M | $399M | $408M | |
| Capital Leases | $58M | $58M | $71M | $77M | $89M | $112M | $106M | $0 | · | · | · | |
| Deferred Tax | $310.0K | $345.0K | $522.0K | $439.0K | $2M | $626.0K | $11M | $18M | $37M | $643.0K | $16M | |
| Other Non-current Liabilities | $75M | $97M | $107M | $110M | $106M | $102M | $97M | $112M | $127M | $77M | $91M | |
| Total Liabilities | $600M | $817M | $987M | $924M | $994M | $1.06B | $894M | $913M | $885M | $810M | $680M | |
| Long-term Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | $417M | $254M | |
| Total Debt | $224M | $394M | $503M | $402M | $376M | $335M | $362M | $430M | $389M | · | $250M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | |
| Retained Earnings | $1.86B | $1.71B | $1.87B | $1.94B | $1.91B | $1.84B | $1.73B | $1.64B | $1.61B | $1.56B | $1.49B | |
| Treasury Stock | $1.58B | $1.56B | $1.57B | $1.57B | $1.53B | $1.46B | $1.32B | $1.33B | $1.30B | $1.25B | $1.02B | |
| AOCI | $-116M | $-125M | $-100M | $-87M | $-74M | $-65M | $-85M | $-80M | $-66M | $-84M | $-71M | |
| Stockholders' Equity | $805M | $651M | $822M | $897M | $913M | $894M | $875M | $782M | $705M | $664M | $826M | |
| Liabilities + Equity | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B | $1.96B | $1.77B | $1.69B | $1.59B | $1.47B | $1.51B |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $52M | $70M | $71M | $73M | $76M | $74M | $77M | $83M | $72M | $72M | $71M | |
| Stock-based Comp | $24M | $15M | $16M | $12M | $23M | $24M | $10M | $27M | $19M | $9M | $7M | |
| Deferred Tax | $20.0K | $-55M | $-15M | $-51M | $6M | $-14M | $-288.0K | $-19M | $44M | $-181.0K | $21M | |
| Amort. of Intangibles | $7M | $12M | $12M | $10M | $12M | $10M | $13M | $18M | $8M | $8M | $9M | |
| Restructuring | · | · | · | · | · | · | $22M | $22M | · | · | · | |
| Other Non-cash | $-156M | $229M | $39M | $-30M | $-112M | $104M | $-82M | $-10M | $38M | · | $90M | |
| Operating Cash Flow | $80M | $112M | $119M | $108M | $142M | $379M | $178M | $203M | $303M | $275M | $322M | |
| CapEx | $34M | $42M | $58M | $59M | $69M | $64M | $66M | $70M | $60M | $50M | $57M | |
| Investing Cash Flow | $171M | $-38M | $-135M | $-67M | $-89M | $-79M | $-71M | $-109M | $-92M | $-58M | $-61M | |
| Debt Issued | $55M | $15M | $110M | $460M | $155M | $115M | $145M | $582M | $67M | $234M | $36M | |
| Net Debt Issued | $-170M | $-110M | $100M | $28M | $40M | $-28M | $-69M | $30M | $-36M | · | $36M | |
| Stock Repurchased | $20M | $0 | $13M | $70M | $80M | $144M | $825.0K | $70M | $72M | $247M | $164M | |
| Net Stock Activity | $-20M | $0 | $-13M | $-70M | $-80M | $-144M | $-825.0K | $-70M | $-72M | · | $-164M | |
| Dividends Paid | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | $78M | $81M | |
| Financing Cash Flow | $-202M | $-133M | $11M | $-100M | $-105M | $-245M | $-155M | $-117M | $-160M | $-135M | $-236M | |
| Net Change in Cash | $52M | $-69M | $-9M | $-75M | $-63M | $67M | $-51M | $-39M | $69M | $68M | $939.0K | |
| Taxes Paid | $41M | $30M | $32M | $42M | $96M | $56M | $98M | $123M | $78M | $123M | $50M | |
| Free Cash Flow | $46M | $70M | $60M | $49M | $73M | $315M | $112M | $132M | $242M | · | $265M | |
| Levered FCF | · | · | $52M | $33M | $66M | $306M | $99M | $120M | $232M | · | $261M |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% | 74.5% | 76.0% | 76.3% | 78.0% | · | · | |
| Operating Margin | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% | 10.0% | 11.1% | 9.0% | 12.0% | · | · | |
| Net Margin | 10.8% | -8.5% | 0.44% | 4.7% | 5.5% | 7.4% | 7.2% | 4.5% | 5.7% | · | · | |
| Pretax Margin | 13.2% | -10.1% | 1.4% | 4.0% | 8.6% | 9.9% | 10.5% | 8.2% | 11.7% | · | · | |
| EBITDA Margin | 8.0% | -4.7% | 6.0% | 8.2% | 11.5% | 12.8% | 14.2% | 12.1% | 15.2% | · | · | |
| ROA | 11.2% | -8.9% | 0.47% | 5.6% | 7.6% | 10.3% | 10.0% | 7.4% | 8.5% | · | 8.5% | |
| ROE | 22.0% | -19.9% | 1.0% | 11.6% | 16.3% | 21.6% | 20.9% | 16.4% | 18.9% | · | 15.0% | |
| ROIC | 5.2% | -12.2% | 1.2% | 10.0% | 11.5% | 15.6% | 14.7% | 11.0% | 12.2% | · | 14.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 | 1.7 | 2.1 | 1.8 | 1.7 | · | 1.7 | |
| Quick Ratio | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 | 0.9 | 1.0 | 0.9 | 1.0 | · | 0.7 | |
| Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.6 | · | 0.3 | |
| LT Debt / Equity | 0.3 | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | · | 0.2 | |
| Interest Coverage | · | · | 1.9 | 8.2 | 21.3 | 19.7 | 13.9 | 11.0 | 12.4 | · | 31.0 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 1.1 | 1.1 | 1.2 | 1.4 | 1.4 | 1.4 | 1.6 | 1.5 | · | · | |
| Inventory Turnover | 2.5 | 2.3 | 2.0 | 1.7 | 1.9 | 2.2 | 2.0 | 2.3 | 2.0 | · | 1.6 | |
| Receivables Turnover | 32.9 | 31.6 | 32.8 | 50.2 | 51.5 | 45.4 | · | · | · | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $29.53 | $34.88 | $39.49 | $44.05 | $52.42 | $48.93 | $43.28 | $47.44 | $41.55 | · | · | |
| Cash Flow / Share | $1.60 | $2.25 | $2.38 | $2.14 | $2.75 | $7.19 | $3.18 | $3.59 | $5.52 | · | $5.45 | |
| Dividend Paid / Share | · | · | · | · | · | · | · | · | · | · | $0.35 | |
| EPS (TTM) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | · | $2.25 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -14.3% | -12.0% | -11.5% | -17.4% | 4.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.6% | -13.7% | -8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -10.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -91.8% | -27.6% | -21.2% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 15.4% | · | -63.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.6% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -91.8% | -28.8% | -23.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 15.2% | · | -64.5% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.5% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -31.5% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B | $2.58B | $2.42B | $2.68B | $2.28B | · | $2.25B | |
| Net Income TTM | $160M | $-147M | $9M | $105M | $147M | $191M | $174M | $122M | $129M | · | $133M | |
| P/E | 3.0 | -2.3 | 114.2 | 20.4 | 17.7 | 15.0 | 13.2 | 28.4 | 28.9 | · | 16.8 | |
| Earnings Yield | 33.1% | -42.8% | 0.88% | 4.9% | 5.6% | 6.6% | 7.6% | 3.5% | 3.5% | · | 5.9% | |
| Payout Ratio | 7.4% | -8.1% | 903.1% | 73.5% | 51.8% | 41.0% | 47.4% | 66.1% | 58.8% | · | 61.0% | |
| Annual Payout | $12M | $12M | $78M | $77M | $76M | $78M | $82M | $81M | $76M | · | $81M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $320M | $321M | $370M | $364M | $386M | $364M | $446M | $430M | $439M | $417M | $489M | $499M | $500M | $481M | $522M | $538M | |
| Cost of Revenue | $102M | $106M | $108M | $107M | $120M | $118M | $166M | $129M | $132M | $123M | $136M | $207M | $136M | $134M | $148M | $174M | |
| Gross Profit | $218M | $214M | $262M | $257M | $266M | $247M | $279M | $301M | $307M | $294M | $352M | $292M | $365M | $348M | $375M | $364M | |
| SG&A Expense | $91M | $99M | $107M | $105M | $107M | $113M | $121M | $116M | $118M | $125M | $145M | $131M | $137M | $134M | $128M | $138M | |
| Operating Expenses | $278M | $210M | $239M | $235M | $235M | $257M | $332M | $283M | $433M | $285M | $336M | $319M | $322M | $332M | $347M | $385M | |
| Operating Income | $-59M | $4M | $23M | $22M | $31M | $-10M | $-53M | $18M | $-126M | $9M | $16M | $-26M | $43M | $16M | $27M | $-20M | |
| Interest Expense | · | · | · | · | · | · | · | $6M | $7M | $7M | · | $8M | $6M | $5M | · | · | |
| Other Non-op | $-534.0K | $3M | $-1M | $-2M | $-843.0K | $-28M | $1M | $2M | $629.0K | $-396.0K | $633.0K | $-551.0K | $376.0K | $3M | $10M | $-9M | |
| Pretax Income | $-63M | $3M | $18M | $16M | $27M | $135M | $-58M | $13M | $-132M | $1M | $9M | $-34M | $37M | $15M | $24M | $-29M | |
| Income Tax | $187M | $763.0K | $4M | $-1M | $6M | $27M | $-22M | $5M | $-13M | $2M | $2M | $3M | $10M | $3M | $-33M | $-4M | |
| Net Income | $-250M | $2M | $14M | $17M | $21M | $108M | $-36M | $8M | $-118M | $-533.0K | $7M | $-37M | $27M | $11M | $57M | $-25M | |
| EPS (Basic) | $-5.14 | $0.04 | $0.31 | $0.35 | $0.43 | $2.16 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.16 | $-0.51 | |
| EPS (Diluted) | $-5.14 | $0.04 | $0.27 | $0.34 | $0.43 | $2.14 | $-0.73 | $0.17 | $-2.38 | $-0.01 | $0.14 | $-0.74 | $0.54 | $0.23 | $1.15 | $-0.51 | |
| Shares (Basic) | 48,596,000 | 48,202,000 | · | 49,398,000 | 49,441,000 | 49,764,000 | · | 49,707,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 49,931,000 | 49,644,000 | · | 50,199,000 | |
| Shares (Diluted) | 48,596,000 | 49,422,000 | · | 50,310,000 | 49,499,000 | 50,328,000 | · | 49,733,000 | 49,688,000 | 49,538,000 | · | 49,859,000 | 50,161,000 | 50,058,000 | · | 50,199,000 | |
| EBITDA | $-47M | $16M | · | $34M | $44M | $4M | · | $36M | $-108M | $27M | · | $-8M | $60M | $33M | · | $-2M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $190M | $199M | $239M | $252M | $264M | $204M | $187M | $228M | $224M | $213M | · | $233M | $236M | $230M | · | $294M | |
| Short-term Investments | $2M | $2M | $1M | $1M | $1M | $10M | $11M | $10M | $9M | $9M | · | $17M | $17M | $17M | · | $14M | |
| Receivables | $49M | $45M | $40M | $49M | $60M | $57M | $51M | $69M | $72M | $67M | · | $77M | $67M | $60M | · | $48M | |
| Inventory | $191M | $179M | $179M | $179M | $180M | $189M | $190M | $248M | $244M | $265M | · | $291M | $372M | $367M | · | $327M | |
| Prepaid Expense | $76M | $99M | $90M | $68M | $66M | $66M | $73M | $99M | $106M | $94M | · | $83M | $101M | $100M | · | $94M | |
| Other Current Assets | · | · | $13M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $508M | $523M | $548M | $548M | $572M | $525M | $539M | $653M | $654M | $647M | · | $701M | $793M | $774M | · | $778M | |
| PP&E (Net) | $380M | $382M | $377M | $375M | $374M | $380M | $380M | $411M | $412M | $423M | · | $429M | $430M | $438M | · | $433M | |
| PP&E (Gross) | · | · | $768M | · | · | · | $733M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $391M | · | · | · | $353M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $5M | $84M | $84M | $84M | $84M | $84M | $84M | $100M | $100M | $231M | · | $229M | $229M | $206M | · | $206M | |
| Intangibles | $38M | $39M | $43M | $44M | $46M | $48M | $74M | $85M | $88M | $102M | · | $109M | $113M | $65M | · | $69M | |
| Other Non-current Assets | $126M | $279M | $280M | $293M | $291M | $276M | $298M | $248M | $243M | $246M | · | $238M | $234M | $243M | · | $172M | |
| Total Assets | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B | |
| Accounts Payable | $38M | $29M | $26M | $29M | $29M | $34M | $35M | $33M | $36M | $32M | · | $49M | $50M | $49M | · | $42M | |
| Accrued Liabilities | $199M | $208M | $218M | $206M | $220M | $207M | $218M | $247M | $242M | $247M | · | $245M | $256M | $276M | · | $281M | |
| Current Liabilities | $256M | $257M | $264M | $254M | $284M | $260M | $297M | $339M | $309M | $309M | · | $434M | $445M | $373M | · | $366M | |
| Capital Leases | $50M | $54M | $58M | $62M | $62M | $62M | $58M | $68M | $70M | $74M | · | $68M | $74M | $79M | · | $78M | |
| Deferred Tax | · | · | $310.0K | · | · | · | $345.0K | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $79M | $68M | $75M | $99M | $96M | $96M | $97M | $95M | $93M | $95M | · | $106M | $111M | $108M | · | $95M | |
| Total Liabilities | $579M | $583M | $600M | $625M | $656M | $637M | $817M | $876M | $900M | $932M | · | $971M | $998M | $932M | · | $921M | |
| Long-term Debt | $214M | $224M | $224M | $229M | $249M | $239M | $394M | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Total Debt | $214M | $224M | · | $229M | $249M | $239M | · | $433M | $458M | $483M | · | $503M | $508M | $420M | · | $425M | |
| Common Stock | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | $91.0K | · | $91.0K | $91.0K | $91.0K | · | $91.0K | |
| Retained Earnings | $1.61B | $1.86B | $1.86B | $1.85B | $1.83B | $1.82B | $1.71B | $1.75B | $1.75B | $1.87B | · | $1.88B | $1.94B | $1.93B | · | $1.90B | |
| Treasury Stock | $1.56B | $1.56B | $1.58B | $1.57B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | $1.56B | · | $1.57B | $1.56B | $1.56B | · | $1.56B | |
| AOCI | $-118M | $-118M | $-116M | $-117M | $-114M | $-124M | $-125M | $-105M | $-117M | $-111M | · | $-109M | $-101M | $-91M | · | $-109M | |
| Stockholders' Equity | $543M | $794M | $805M | $800M | $788M | $754M | $651M | $707M | $686M | $810M | · | $822M | $895M | $893M | · | $842M | |
| Liabilities + Equity | $1.12B | $1.38B | $1.41B | $1.42B | $1.44B | $1.39B | $1.47B | $1.58B | $1.59B | $1.74B | · | $1.79B | $1.89B | $1.82B | · | $1.76B |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $12M | $13M | $12M | $13M | $14M | $16M | $17M | $18M | $18M | $19M | $18M | $17M | $17M | $19M | $18M | |
| Stock-based Comp | $1M | $4M | $3M | $6M | $6M | $9M | $3M | $3M | $4M | $4M | $3M | $4M | $5M | $4M | $3M | $3M | |
| Other Non-cash | · | $-22M | · | · | · | $-131M | · | · | · | $-19M | · | · | · | $-54M | · | · | |
| Operating Cash Flow | $11M | $-4M | $17M | $27M | $36M | $389.0K | $26M | $31M | $51M | $3M | $54M | $51M | $36M | $-22M | $26M | $28M | |
| CapEx | $6M | $14M | $11M | $10M | $18.0K | $14M | $13M | $9M | $8M | $12M | $20M | $12M | $15M | $11M | $14M | $25M | |
| Investing Cash Flow | $-6M | $-14M | $-10M | $-10M | $9M | $182M | $-14M | $-7M | $-9M | $-9M | $-15M | $-12M | $-93M | $-15M | $-13M | $-25M | |
| Debt Issued | $0 | $225M | $0 | $40M | $15M | $0 | $0 | $15M | $0 | $0 | $0 | $0 | $90M | $20M | $0 | $0 | |
| Net Debt Issued | · | $0 | · | · | · | $-155M | · | · | · | $-20M | · | · | · | $18M | · | · | |
| Stock Repurchased | $0 | $5M | $10M | $5M | $0 | $5M | $0 | $0 | $0 | $0 | $0 | $13M | $0 | $0 | $10M | $40M | |
| Net Stock Activity | · | $-5M | · | · | · | $-5M | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Financing Cash Flow | $-13M | $-20M | $-19M | $-27M | $9M | $-166M | $-44M | $-29M | $-29M | $-32M | $-20M | $-38M | $68M | $1M | $-51M | $-61M | |
| Net Change in Cash | $-9M | $-40M | $-13M | $-12M | $60M | $17M | $-41M | $4M | $12M | $-44M | $23M | $-2M | $6M | $-35M | $-29M | $-70M | |
| Free Cash Flow | · | $-18M | · | · | · | $-13M | · | · | · | $-9M | · | · | · | $-34M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-5M | · | · | · | · | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.2% | 66.9% | · | 70.5% | 68.8% | 67.8% | · | 70.1% | 70.0% | 70.5% | · | 58.6% | 72.9% | 72.2% | · | 67.7% | |
| Operating Margin | -18.5% | 1.3% | · | 5.9% | 8.0% | -2.7% | · | 4.2% | -28.6% | 2.1% | · | -5.3% | 8.5% | 3.3% | · | -3.8% | |
| Net Margin | -78.0% | 0.57% | · | 4.7% | 5.5% | 29.5% | · | 1.9% | -26.9% | -0.13% | · | -7.4% | 5.4% | 2.4% | · | -4.7% | |
| Pretax Margin | -19.7% | 0.81% | · | 4.4% | 7.1% | 36.9% | · | 3.1% | -30.0% | 0.26% | · | -6.9% | 7.4% | 3.0% | · | -5.4% | |
| EBITDA Margin | -14.6% | 5.1% | · | 9.3% | 11.3% | 1.2% | · | 8.3% | -24.6% | 6.5% | · | -1.6% | 11.9% | 6.9% | · | -0.39% | |
| ROA | -19.5% | 0.13% | · | 1.1% | 1.4% | 6.9% | · | 0.49% | -6.8% | -0.03% | · | -2.1% | 1.4% | 0.61% | · | -1.4% | |
| ROE | -37.5% | 0.24% | · | 2.3% | 2.9% | 13.8% | · | 1.1% | -15.0% | -0.06% | · | -4.4% | 2.9% | 1.2% | · | -2.9% | |
| ROIC | -31.0% | 0.28% | · | 2.2% | 2.3% | -0.80% | · | 1.0% | -9.8% | -0.33% | · | -2.1% | 2.2% | 0.95% | · | -1.4% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.0 | · | 2.2 | 2.0 | 2.0 | · | 1.9 | 2.1 | 2.1 | · | 1.6 | 1.8 | 2.1 | · | 2.1 | |
| Quick Ratio | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.0 | · | 0.9 | 1.0 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 1.0 | |
| Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | |
| LT Debt / Equity | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.5 | 0.6 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | 2.8 | -18.7 | 1.2 | · | · | · | · | · | · |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 0.5 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | |
| Receivables Turnover | 5.9 | 6.3 | · | 6.2 | 5.9 | 5.9 | · | 5.9 | 6.3 | 6.6 | · | 8.0 | 9.0 | 8.6 | · | 10.7 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $6.59 | $6.49 | · | $7.24 | $7.80 | $7.24 | · | $8.65 | $8.84 | $8.42 | · | $10.00 | $9.97 | $9.62 | · | $10.71 | |
| Cash Flow / Share | · | $-0.08 | · | · | · | $0.01 | · | · | · | $0.07 | · | · | · | $-0.44 | · | · | |
| EPS (TTM) | $-4.49 | $1.08 | · | $2.18 | $2.01 | $-0.80 | · | $-2.08 | $-2.99 | $-0.07 | · | $1.18 | $1.41 | $1.54 | · | $0.75 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.38B | $1.44B | · | $1.56B | $1.63B | $1.68B | · | $1.78B | $1.84B | $1.90B | · | $2.00B | $2.04B | $2.10B | · | $2.38B | |
| Net Income TTM | $-216M | $55M | · | $110M | $101M | $-39M | · | $-103M | $-148M | $-3M | · | $59M | $70M | $77M | · | $38M | |
| P/E | -1.2 | 6.7 | · | 5.6 | 4.0 | -9.1 | · | -3.5 | -3.5 | -197.6 | · | 18.0 | 23.5 | 25.5 | · | 44.5 | |
| Earnings Yield | -85.0% | 14.8% | · | 17.9% | 25.2% | -11.0% | · | -28.2% | -28.4% | -0.51% | · | 5.6% | 4.2% | 3.9% | · | 2.2% | |
| Payout Ratio | · | 156.5% | · | · | · | 2.8% | · | · | · | -558.9% | · | · | · | 170.5% | · | · | |
| Annual Payout | $12M | $12M | · | $12M | $12M | $12M | · | $28M | $45M | $61M | · | $77M | $77M | $77M | · | $77M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Marża Brutto % | 69.5% | 68.2% | 68.9% | 71.7% | 75.0% |
| Marża Operacyjna % | 4.4% | -8.8% | 2.5% | 5.0% | 8.7% |
| Zysk netto | $160M | $-147M | $9M | $105M | $147M |
| Rozwodniony EPS | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.3 | 0.6 | 0.6 | 0.4 | 0.4 |
| Wskaźnik bieżący | 2.1 | 1.8 | 2.1 | 2.1 | 1.6 |
| Wskaźnik Szybkości | 1.1 | 0.8 | 1.0 | 0.9 | 0.7 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $46M | $70M | $60M | $49M | $73M |
Właściciele instytucjonalni (13F) 183 emitenci · $241.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 28 (+2 vs poprzedni kw.) | 35 (+9 vs poprzedni kw.) | 52 (-13 vs poprzedni kw.) | 60 (-4 vs poprzedni kw.) | -182K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $41 729 944 | 4 337 832 | 17,26% | Akcje |
| BlackRock, Inc. | $22 787 834 | 4 315 878 | 9,42% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $12 150 906 | 2 301 308 | 5,02% | Akcje |
| Coppell Advisory Solutions LLC | $11 266 612 | 235 | 4,66% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 822 104 | 2 049 641 | 4,47% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $9 486 817 | 1 796 745 | 3,92% | Akcje |
| Prescott Group Capital Management, L.L.C. | $9 475 530 | 1 794 608 | 3,92% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $9 170 600 | 1 736 856 | 3,79% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $8 488 614 | 1 607 692 | 3,51% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7 671 507 | 1 452 937 | 3,17% | Akcje |
| CastleKnight Management LP | $7 337 262 | 1 389 633 | 3,03% | Akcje |
| TWO SIGMA ADVISERS, LP | $7 314 086 | 760 300 | 3,02% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $6 702 971 | 1 269 191 | 2,77% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $6 170 388 | 1 168 634 | 2,55% | Akcje |
| STATE STREET CORP | $5 330 941 | 1 009 648 | 2,20% | Akcje |
| PRUDENTIAL FINANCIAL INC | $4 890 795 | 926 287 | 2,02% | Akcje |
| MORGAN STANLEY | $4 781 192 | 905 527 | 1,98% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $4 024 565 | 789 131 | 1,66% | Akcje |
| CITADEL ADVISORS LLC | $3 456 167 | 654 577 | 1,43% | Akcje |
| GOLDMAN SACHS GROUP INC | $3 266 432 | 618 642 | 1,35% | Akcje |
| Bank of New York Mellon Corp | $2 862 799 | 542 197 | 1,18% | Akcje |
| NORTHERN TRUST CORP | $2 191 300 | 415 019 | 0,91% | Akcje |
| Allianz Asset Management GmbH | $2 074 074 | 392 817 | 0,86% | Akcje |
| D. E. Shaw & Co., Inc. | $2 010 043 | 380 690 | 0,83% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 674 151 | 317 074 | 0,69% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $1 627 908 | 308 316 | 0,67% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 590 690 | 301 267 | 0,66% | Akcje |
| Empowered Funds, LLC | $1 321 542 | 250 292 | 0,55% | Akcje |
| AXA Investment Managers S.A. | $1 307 268 | 107 241 | 0,54% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $1 212 651 | 166 573 | 0,50% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 081 872 | 204 900 | 0,45% | Akcje |
| Nuveen, LLC | $951 700 | 180 246 | 0,39% | Akcje |
| Vanguard Global Advisers, LLC | $936 603 | 177 387 | 0,39% | Akcje |
| FIRST TRUST ADVISORS LP | $925 594 | 175 302 | 0,38% | Akcje |
| Russell Investments Group, Ltd. | $888 036 | 168 189 | 0,37% | Akcje |
| XTX Topco Ltd | $823 379 | 155 943 | 0,34% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $803 590 | 152 195 | 0,33% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $799 852 | 151 487 | 0,33% | Akcje |
| JPMORGAN CHASE & CO | $751 441 | 142 588 | 0,31% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $728 614 | 137 995 | 0,30% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $670 856 | 127 056 | 0,28% | Akcje |
| UBS Group AG | $647 482 | 122 629 | 0,27% | Akcje |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $628 125 | 118 963 | 0,26% | Akcje |
| ExodusPoint Capital Management, LP | $616 408 | 116 744 | 0,25% | Akcje |
| Cubist Systematic Strategies, LLC | $571 087 | 46 849 | 0,24% | Akcje |
| RITHOLTZ WEALTH MANAGEMENT | $527 566 | 99 918 | 0,22% | Akcje |
| Inspire Investing, LLC | $515 631 | 70 828 | 0,21% | Akcje |
| STRS OHIO | $511 104 | 96 800 | 0,21% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $467 376 | 64 200 | 0,19% | Akcje |
| Nebula Research & Development LLC | $460 288 | 57 608 | 0,19% | Akcje |
Aktywiści i właściciele 5%+ 9 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 11 lutego 2008 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 2 kwietnia 2007 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 26 marca 2007 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 15 marca 2007 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 grudnia 2006 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 9 czerwca 2006 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 8 maja 2006 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 20 stycznia 2006 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 15 grudnia 2005 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 57 insiderów · 31 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ryan S Napierski | President and CEO | 6 marca 2026 A | 1 001 905 | 0 | 0 | $0 |
| Ritch N Wood | Chief Executive Officer | 17 czerwca 2021 S | 175 239 | 0 | 0 | $0 |
| Truman M Hunt | President & CEO | 27 lutego 2017 A | 575 559 | 0 | 0 | $0 |
| James D Thomas | Chief Financial Officer | 6 marca 2026 A | 267 102 | 0 | 0 | $0 |
| Mark H Lawrence | Chief Financial Officer | 2 marca 2023 M | 57 146 | 0 | 0 | $0 |
| Scott E Schwerdt | President, Americas Region | 18 grudnia 2015 A | 34 585 | 0 | 0 | $0 |
| Gary Sumihiro | President | 20 grudnia 2007 A | 800 | 0 | 0 | $0 |
| Luke Loo | President | 20 grudnia 2007 A | 5 625 | 0 | 0 | $0 |
| Larry V Macfarlane | President, Big Planet | 26 lutego 2007 A | 6 005 | 0 | 0 | $0 |
| Robert S Conlee | President, North Asia & Japan | 26 lutego 2007 A | 4 549 | 0 | 0 | $0 |
| Lori H Bush | President -Nu Skin Division | 31 sierpnia 2005 A | 11 453 | 0 | 0 | $0 |
| Chayce David Clark | EVP, COO and CLO | 6 marca 2026 A | 390 746 | 0 | 0 | $0 |
| Justin S Keisel | EVP, President of Global Sales | 6 marca 2026 A | 160 170 | 0 | 0 | $0 |
| Steven Keith Hatchett | Chief Product Officer | 6 marca 2026 A | 260 818 | 1 | 0 | $52 855 |
| Connie Mang Yee Tang | Chief Global Growth Officer | 21 kwietnia 2023 F | 43 204 | 0 | 0 | $0 |
| Joseph Y Chang | Chief Scientific Officer | 2 marca 2023 M | 21 234 | 0 | 0 | $0 |
| Steven Lund | Exec. Chairman of the Board | 1 marca 2023 G | 113 574 | 0 | 0 | $0 |
| Jeffrey Clark Bettinger | SVP, People and Places Officer | 5 października 2021 S | 16 068 | 0 | 0 | $0 |
| Matthew D Dorny | General Counsel | 2 lipca 2021 M | 47 159 | 0 | 0 | $0 |
| Daniel R Chard | Pres Global Sales & Operations | 6 lipca 2015 M | 48 111 | 0 | 0 | $0 |
| Blake Roney | Chairman of the Board | 3 czerwca 2011 G | 3 216 458 | 0 | 0 | $0 |
| Ashok Pahwa | Chief Marketing Officer | 28 sierpnia 2009 F | 3 322 | 0 | 0 | $0 |
| Jack Peterson | Vice President | 20 grudnia 2007 A | 6 984 | 0 | 0 | $0 |
| Mark L Adams | Chief Information Officer | 20 grudnia 2007 A | 11 410 | 0 | 0 | $0 |
| Claire Averett | Vice President | 4 września 2007 F | 3 230 | 0 | 0 | $0 |
| Brett Nelson | Vice President | 4 września 2007 F | 4 202 | 0 | 0 | $0 |
| Corey B Lindley | Executive Vice President | 1 września 2006 A | 20 750 | 0 | 0 | $0 |
| Mark Wolfert | Regional Vice President- | 31 sierpnia 2005 A | 0 | 0 | 0 | $0 |
| Michael D Smith | Vice President-Gov't Relations | 31 sierpnia 2005 A | 1 734 | 0 | 0 | $0 |
| Richard W King | Chief Information Officer | 31 sierpnia 2005 A | 5 987 | 0 | 0 | $0 |
| Brooke Roney | Senior Vice President | 2 grudnia 2004 G | 825 000 | 0 | 0 | $0 |
| Edwina D Woodbury | Dyrektor | 9 września 2026 A | 62 474 | 0 | 1 | $-41 057 |
| James M Winett | Dyrektor | 2 czerwca 2026 S | 37 448 | 0 | 1 | $-40 481 |
| Laura Nathanson | Dyrektor | 1 czerwca 2026 A | 57 116 | 0 | 1 | $-18 009 |
| Emma S. Battle | Dyrektor | 1 czerwca 2026 A | 57 648 | 0 | 0 | $0 |
| Pisano R. Thomas | Dyrektor | 1 czerwca 2026 A | 116 827 | 0 | 0 | $0 |
| Mark A Zorko | Dyrektor | 1 czerwca 2026 A | 60 586 | 0 | 0 | $0 |
| Daniel W Campbell | Dyrektor | 1 czerwca 2026 A | 65 859 | 0 | 0 | $0 |
| Zheqing Shen | Dyrektor | 7 czerwca 2024 A | 33 195 | 0 | 0 | $0 |
| Andrew D Lipman | Dyrektor | 28 maja 2024 S | 23 225 | 0 | 0 | $0 |
| Neil H Offen | Dyrektor | 21 maja 2019 M | 10 083 | 0 | 0 | $0 |
| Nevin N Andersen | Dyrektor | 21 maja 2019 M | 34 045 | 0 | 0 | $0 |
| Zhequing Shen | Dyrektor | 11 maja 2017 A | 3 456 | 0 | 0 | $0 |
| Patricia Negron | Dyrektor | 13 maja 2015 G | 7 592 | 0 | 0 | $0 |
| Sandra Tillotson | Dyrektor | 4 maja 2012 M | 1 885 845 | 0 | 0 | $0 |
| David D. Ussery | Dyrektor | 9 lutego 2012 M | 13 222 | 0 | 0 | $0 |
| Ej Jake Garn | Dyrektor | 24 maja 2011 A | 17 272 | 0 | 0 | $0 |
| Desmond C Wong | Dyrektor | 15 maja 2007 A | 1 400 | 0 | 0 | $0 |
| Christine Mccormick Day | Dyrektor | 15 maja 2007 A | 1 400 | 0 | 0 | $0 |
| Allen D Andersen | Dyrektor | 25 maja 2006 A | 2 500 | 0 | 0 | $0 |
| Paula Hawkins | Dyrektor | 25 maja 2006 A | · | 0 | 0 | $0 |
| Jose Ferreira JR | Dyrektor | 25 maja 2006 A | · | 0 | 0 | $0 |
| Nancy Roney | Posiadacz 10% | 3 grudnia 2004 G | 8 541 469 | 0 | 0 | $0 |
| Nedra D Roney | Posiadacz 10% | 27 października 2003 S | 1 845 765 | 0 | 0 | $0 |
| Andrew Fan | · | 20 grudnia 2007 A | 22 815 | 0 | 0 | $0 |
| Melisa Quijano | · | 4 września 2007 A | 6 901 | 0 | 0 | $0 |
| Takashi Bamba | · | 2 września 2003 A | · | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 24 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| MYLD · Cambria ETF Trust | 0,99% | 64 849 NS | 31 lipca 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 122 929 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,08% | 123 628 SH | 19 sierpnia 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 51 988 SH | 19 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,06% | 166 825 SH | 11 września 2026 | Dziennie |
| VDC · VANGUARD WORLD FUND | 0,03% | 570 468 SH | 19 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 42 579 SH | 19 sierpnia 2026 | Dziennie |
| EBIT · Harbor ETF Trust | 0,02% | 424 NS | 31 lipca 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 220 644 NS | 31 lipca 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 280 867 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 1 309 534 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 23 316 NS | 31 lipca 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 125 157 NS | 31 lipca 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 34 871 SH | 1 października 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 42 209 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4 155 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 69 540 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 12 201 SH | 3 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 9 320 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 562 165 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 465 550 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 734 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 494 441 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 109 833 SH | 11 września 2026 | Dziennie |
NUS Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
1 analityków · 2026-10-01Średnia cel $12.77 +177,0%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| NUS | · | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| HNST | $291M | -18.4 | -1.9% | -4.2% | -8.8% | 33.3% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.